Compile Data Set for Download or QSAR
maximum 50k data
Found 1097 Enz. Inhib. hit(s) with all data for entry = 10999
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583581(US11524959, Compound 473.)
Affinity DataIC50:  5nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584177(US11524959, Compound 1069.)
Affinity DataIC50:  6nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583839(US11524959, Compound 731.)
Affinity DataIC50:  6nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584086(US11524959, Compound 978. | US11524959, Compound 9...)
Affinity DataIC50:  7nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583500(US11524959, Compound 392. | methyl 6-(2-{5-[(1R,4R...)
Affinity DataIC50:  9nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583961(US11524959, Compound 853.)
Affinity DataIC50:  9nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583204(N-[3-(2-(5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1...)
Affinity DataIC50:  10nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583495(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  11nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583501(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  11nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583503(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583578(US11524959, Compound 470.)
Affinity DataIC50:  12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583308(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584051(US11524959, Compound 943.)
Affinity DataIC50:  12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583472(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583475(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583483(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583496(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583260(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583584(US11524959, Compound 476.)
Affinity DataIC50:  13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583588(US11524959, Compound 480.)
Affinity DataIC50:  14nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584110(US11524959, Compound 1002. | US11524959, Compound ...)
Affinity DataIC50:  15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584173(US11524959, Compound 1065.)
Affinity DataIC50:  15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583213(US11524959, Compound 105. | {4-[(2-{5-[(1R,4R,7R)-...)
Affinity DataIC50:  15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583314(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583807(US11524959, Compound 699.)
Affinity DataIC50:  15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583468((1R,4R,7R)-2-{2-[1- (cyclopropyljmethyl)-6-(2- met...)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583237(5-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583573(US11524959, Compound 465. | US11524959, Compound 4...)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583601(US11524959, Compound 493.)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583323(5-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583884(US11524959, Compound 776.)
Affinity DataIC50:  16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583443(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583298(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583319(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583967(US11524959, Compound 859.)
Affinity DataIC50:  17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583160((1R,4R,7R)-2-{2-[1- (cyclopropylmethyl)-6-[(2- met...)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583231(5-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583583(US11524959, Compound 475.)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583678(US11524959, Compound 570.)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583325(6-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583713(US11524959, Compound 605.)
Affinity DataIC50:  18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583465(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583466(5-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583197(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583613(US11524959, Compound 505.)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583831(US11524959, Compound 723.)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583853(US11524959, Compound 745.)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583876(US11524959, Compound 768.)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584035(US11524959, Compound 927.)
Affinity DataIC50:  19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM584205(US11524959, Compound 1097.)
Affinity DataIC50:  20nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1097 total ) | Next | Last >>
Jump to: